PROCTER & GAMBLE HEALTH Financial Statement Analysis
|
||
The Revenues of PROCTER & GAMBLE HEALTH have decreased by -18.86% YoY .
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 16.64 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
PROCTER & GAMBLE HEALTH Last 5 Annual Financial Results
[BOM: 500126|NSE : PGHL]
Standalone | Mar2025 | Jun2024 | Mar2024 | Jun2023 | Jun2022 |
---|---|---|---|---|---|
Revenues | ₹934 Cr | ₹1,151 Cr | ₹1,151 Cr | ₹1,230 Cr | ₹1,114 Cr |
Expenses | ₹616 Cr | ₹845 Cr | ₹845 Cr | ₹905 Cr | ₹847 Cr |
Operating Profit (Excl OI) | ₹318 Cr | ₹306 Cr | ₹306 Cr | ₹325 Cr | ₹268 Cr |
Other Income | ₹10 Cr | ₹16 Cr | ₹16 Cr | ₹18 Cr | ₹13 Cr |
Interest | ₹0.43 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.77 Cr | ₹0.42 Cr |
Depreciation | ₹17 Cr | ₹27 Cr | ₹27 Cr | ₹28 Cr | ₹27 Cr |
Profit Before Tax | ₹312 Cr | ₹273 Cr | ₹273 Cr | ₹314 Cr | ₹253 Cr |
Profit After Tax | ₹234 Cr | ₹201 Cr | ₹201 Cr | ₹229 Cr | ₹193 Cr |
Earnings Per Share (Rs) | ₹141.21 | ₹121.07 | ₹121.07 | ₹138.23 | ₹115.98 |
PAT Margin (%) | 22.78 | 15.96 | 15.96 | 17.28 | 16.35 |
ROE(%) | 44.15 | 31.58 | 31.58 | 33.94 | 29.41 |
ROCE(%) | 58.05 | 42.52 | 42.52 | 46.07 | 38.45 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 10,129.9 Cr |
Revenue (TTM) | : | ₹ 1,272.9 Cr |
Net Profit(TTM) | : | ₹ 300.6 Cr |
EPS (TTM) | : | ₹ 181.1 |
P/E (TTM) | : | 33.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
PROCTER & GAMBLE HEALTH | -2.2% | -3.8% | 17.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 3.7% | -13.5% |
DIVIS LABORATORIES | 7.4% | 9% | 8.2% |
CIPLA | 3.3% | 0.2% | -7.1% |
TORRENT PHARMACEUTICALS | -0.7% | -1.7% | -0.6% |
DR REDDYS LABORATORIES | 1% | -3.2% | -5.2% |
MANKIND PHARMA | -1.6% | -6% | -8.5% |
ZYDUS LIFESCIENCES | 0.6% | -4.8% | -6.7% |
LUPIN | 2.4% | -0.9% | -14.2% |
PROCTER & GAMBLE HEALTH Revenues
[BOM: 500126|NSE : PGHL]
Y-o-Y | -18.86 % |
5 Yr CAGR | -4.31 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹934 Cr | -18.86 | |
Jun2024 | ₹1,151 Cr | 0.00 | |
Mar2024 | ₹1,151 Cr | -6.37 | |
Jun2023 | ₹1,230 Cr | 10.34 | |
Jun2022 | ₹1,114 Cr | - |
PROCTER & GAMBLE HEALTH Operating Profit
[BOM: 500126|NSE : PGHL]
Y-o-Y | 4.05 % |
5 Yr CAGR | 4.43 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹318 Cr | 4.05 | |
Jun2024 | ₹306 Cr | 0.00 | |
Mar2024 | ₹306 Cr | -5.75 | |
Jun2023 | ₹325 Cr | 21.29 | |
Jun2022 | ₹268 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 28.22 % |
5 Yr CAGR | 9.14 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 34.08% | 28.22 | |
Jun2024 | 26.58% | 0.00 | |
Mar2024 | 26.58% | 0.68 | |
Jun2023 | 26.4% | 9.91 | |
Jun2022 | 24.02% | - |
PROCTER & GAMBLE HEALTH Profit After Tax
[BOM: 500126|NSE : PGHL]
Y-o-Y | 16.63 % |
5 Yr CAGR | 5.04 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹234 Cr | 16.63 | |
Jun2024 | ₹201 Cr | 0.00 | |
Mar2024 | ₹201 Cr | -12.42 | |
Jun2023 | ₹229 Cr | 19.19 | |
Jun2022 | ₹193 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 42.73 % |
5 Yr CAGR | 8.64 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 22.78 % | 42.73 | |
Jun2024 | 15.96 % | 0.00 | |
Mar2024 | 15.96 % | -7.64 | |
Jun2023 | 17.28 % | 5.69 | |
Jun2022 | 16.35 % | - |
PROCTER & GAMBLE HEALTH Earnings Per Share (EPS)
[BOM: 500126|NSE : PGHL]
Y-o-Y | 16.64 % |
5 Yr CAGR | 5.04 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹141 | 16.64 | |
Jun2024 | ₹121 | 0.00 | |
Mar2024 | ₹121 | -12.41 | |
Jun2023 | ₹138 | 19.18 | |
Jun2022 | ₹116 | - |
PROCTER & GAMBLE HEALTH Return on Capital Employed (ROCE)
[BOM: 500126|NSE : PGHL]
Y-o-Y | 36.52 % |
5 Yr CAGR | 10.85 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 58.05% | 36.52 | |
Jun2024 | 42.52% | 0.00 | |
Mar2024 | 42.52% | -7.71 | |
Jun2023 | 46.07% | 19.82 | |
Jun2022 | 38.45% | - |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
Current Share Price | : | ₹6,102.4 |
Current MarketCap | : | ₹ 10,129.9 Cr |
Updated EOD on | : | Oct 13,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PROCTER & GAMBLE HEALTH | -2.2% |
-3.8% |
17.3% |
SENSEX | 0.7% |
1.1% |
0.9% |
PROCTER & GAMBLE HEALTH related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE HEALTHCARE | 1.6% | -0% | 1.6% |
BSE 500 | 0.5% | 0.9% | -1.4% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MIDSMALL HEALTHCARE | 1.7% | -0.1% | 7.8% |
You may also like the below Video Courses
FAQ about PROCTER & GAMBLE HEALTH Financials
How the annual revenues of PROCTER & GAMBLE HEALTH have changed ?
The Revenues of PROCTER & GAMBLE HEALTH have decreased by -18.86% YoY .
How the Earnings per Share (EPS) of PROCTER & GAMBLE HEALTH have changed?
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 16.64 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs